Jeff Yass’s Biodesix BDSX Stock Holding History

Jeff Yass’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,050	Closed	-$67K	–	13156
2022 Q2	$67K	Buy	+2,050	New	+$66.6K	﹤0.01%	11792

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jeff Yass's BDSX Position: Q2 2026 in Review

Jeff Yass sold out of Biodesix (BDSX) in Q2 2026, closing a stake of 23,090 shares — an estimated $335K sold.

Jeff Yass first reported a position in BDSX in Q1 2023 and held it in 7 quarters. The position peaked at $1.71M in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Jeff Yass reported no remaining Biodesix position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 23,090 Biodesix shares in Q2 2026, an estimated $335K.
Jeff Yass first reported a position in Biodesix in Q1 2023 and held it in 7 quarters.
Jeff Yass's Biodesix position peaked at $1.71M in Q4 2024.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.